Literature DB >> 1376268

Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.

P Uciechowski1, J E Gessner, R Schindler, R E Schmidt.   

Abstract

The transmembrane protein CD16 (Fc gamma RIII) is detected on activated macrophages, natural killer (NK) cells and a small subset of T lymphocytes. From CD3-CD56+ CD16+bright NK cells and CD3+ CD56+ CD16+dim non-major histocompatibility complex (MHC)-restricted cytotoxic T lymphocyte (CTL) clones were generated reflecting the stable, but different, CD16 expression of the respective peripheral blood subpopulations. To compare the role of CD16 on NK cells and non-MHC-restricted CTL, Fc gamma RIII activation and its mechanisms were investigated using monoclonal antibodies (mAb). Cross-linking of CD16 induced Ca2+ influx in CD16+bright NK clones. In contrast, there was no Ca2+ mobilization after CD16 activation in CD16+dim CTL, which revealed a good response to cross-linking of CD3 antigen. Pretreatment with CD16 mAb alone or cross-linked CD16 mAb did not block the CD3 response of CD16+dim CTL. Again, CD16 cross-linking induced more interferon-gamma transcription in NK cell clones than in non-MHC-restricted CTL clones. Also a higher tumor necrosis factor-alpha production of NK clones after CD16 cross-linking compared to CD16+dim CTL could be observed. These data suggest that after CD16 activation CD16+dim CTL and CD16+bright NK cells use different second messengers. In addition, signal transduction via CD3 and CD16 appears to function independently in CD16+dim non-MHC-restricted CTL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376268     DOI: 10.1002/eji.1830220643

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Potentiation of long-term-cultured lymphokine-activated killer cell cytotoxicity against small-cell lung carcinoma by anti-CD3 x anti-(tumor-associated antigen) bispecific antibody.

Authors:  A Azuma; H Yagita; K Okumura; S Kudoh; H Niitani
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

Review 2.  Expansions of NK-like αβT cells with chronologic aging: novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells.

Authors:  Abbe N Vallejo; Robert G Mueller; David L Hamel; Amanda Way; Jeffrey A Dvergsten; Patricia Griffin; Anne B Newman
Journal:  Ageing Res Rev       Date:  2010-10-12       Impact factor: 10.895

3.  TCR1+ large granular lymphocyte proliferation in rheumatoid arthritis.

Authors:  J G Kuipers; R Jacobs; A Kemper; H Zeidler; R E Schmidt
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

4.  Glycosylation of FcgammaRIII in N163 as mechanism of regulating receptor affinity.

Authors:  Bettina Drescher; Torsten Witte; Reinhold E Schmidt
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

5.  Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Authors:  Stefania Crotta; Annalisa Stilla; Andreas Wack; Annalisa D'Andrea; Sandra Nuti; Ugo D'Oro; Marta Mosca; Franco Filliponi; R Maurizia Brunetto; Ferruccio Bonino; Sergio Abrignani; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

Review 6.  Human CD4(+) T-Cells: A Role for Low-Affinity Fc Receptors.

Authors:  Anil K Chauhan
Journal:  Front Immunol       Date:  2016-06-01       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.